Clinical Trial Update: A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan. [Phase 3]

View source ↗

Summary

A Phase 3 trial in Chinese patients with mild-to-moderate hypertension compared the efficacy of Co-Diovan (valsartan/amlodipine) with Diovan (valsartan).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Co-Diovan (losartan/hydrochlorothiazide)
• DIOVAN (valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED